Abstract: Heart disease is one of the main health problems throughout the world. Early and accurate detection of heart disease is very important to reduce the death rate caused by this condition. One ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

US Secretary of State Marco Rubio has directed the State Department to go back to using Times New Roman typeface as the standard for official papers, a spokesperson told CNN, in a reversal of the ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...